Effects of venlafaxine, buspirone, and placebo on colonic sensorimotor functions in healthy humans

Clinical Gastroenterology and Hepatology

Volumn 1, Issue 3, 2003, Pages 211-218

  Chial, Heather J ^a   Camilleri, Michael ^a   Ferber, Irene ^a   Delgado Aros, Silvia ^a   Burton, Duane ^a   McKinzie, Sanna ^a   Zinsmeister, Alan R ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUSPIRONE; NORADRENALIN UPTAKE INHIBITOR; PLACEBO; SEROTONIN 1A ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; VENLAFAXINE;

ADULT; ARTICLE; BAROSTAT; CLINICAL TRIAL; COLON; COLON DILATATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG BIOAVAILABILITY; DRUG HALF LIFE; FEMALE; HEADACHE; HUMAN; HUMAN EXPERIMENT; INTESTINE CONTRACTION; MALE; MYDRIASIS; NAUSEA; NERVOUSNESS; NORMAL HUMAN; PAIN ASSESSMENT; POSTPRANDIAL STATE; RANDOMIZED CONTROLLED TRIAL; SATIETY; SENSORIMOTOR FUNCTION; STATISTICAL SIGNIFICANCE; VOLUNTEER; VOMITING;

EID: 0141892613     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1542-3565(03)70038-X     Document Type: Article

References (41)

1. Talley NJ, Zinsmeister AR, Van Dyke C, Melton LJ. Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology 1991;101:927-934.
2. Drossman DA. Gastrointestinal illness and the biopsychosocial model. J Clin Gastroenterol 1996;22:252-254.
3. Kim D, Camilleri M. Serotonin: a mediator of the brain-gut connection. Am J Gastroenterol 2000;95:2698-2709.
4. Qian Y, Melikian HE, Rye DB, Levey AI, Blakely RD. Identification and characterization of antidepressant-sensitive serotonin transporter proteins using site-specific antibodies. J Neurosci 1995; 15:1261-1274.
5. Chen JX, Pan H, Rothman TP, Wade PR, Gershon MD. Guinea pig 5-HT transporter: cloning, expression, distribution, and function in intestinal sensory reception. Am J Physiol 1998;275:G433-G448.
6. Chen JJ, Li Z, Pan H, Murphy DL, Tamir H, Koepsell H, Gershon MD. Maintenance of serotonin in the intestinal mucosa and ganglia of mice that lack the high-affinity serotonin transporter: abnormal intestinal motility and the expression of cation transporters. J Neurosci 2001;21:6348-6361.
7. Bengel D, Murphy DL, Andrews AM, Wichems CH, Feltner D, Heils A, Mossner R, Westphal H, Lesch KP. Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methyl-enedioxymethamphetamine ("Ecstasy") in serotonin transporter-deficient mice. Mol Pharmacol 1998;53:649-655.
8. Drossman DA. Diagnosing and treating patients with refractory functional gastrointestinal disorders. Ann Intern Med 1995;123:688-697.
9. Clouse RE. Antidepressants for functional gastrointestinal syndromes. Dig Dis Sci 1994;39:2352-2363.
10. Gorard DA, Libby GW, Farthing MJ. Influence of antidepressants on whole gut and orocaecal transit times in health and irritable bowel syndrome. Aliment Pharmacol Ther 1994;8:159-166.
11. Tack J. A placebo-controlled trial of buspirone, a fundus relaxing drug, in functional dyspepsia: effect on symptoms and gastric sensory and motor function. Gastroenterology 2000;116:G1423.
12. Gorard DA, Libby GW, Farthing MJ. 5-Hydroxytryptamine and human small intestinal motility: effect of inhibiting 5-hydroxytryptamine reuptake. Gut 1994;35:496-500.
13. Martinez JA, Bueno L. Buspirone inhibits corticotropin-releasing factor and stress-induced cecal motor response in rats by acting through 5-HT1A receptors. Eur J Pharmacol 1991;202:379-383.
14. Chial HJ, Camilleri M Burton D, Thomforde G, Olden KW, Stephens D. Selective effects of serotonergic psychoactive agents on gastrointestinal sensorimotor function in health. Am J Physiol Gastrointest Liver Physiol 2003;284:G130-G137.
15. Harvey AT, Rudolph RL, Preskorn SH. Evidence of the dual mechanisms of action of venlafaxine. Arch Gen Psychiatry 2000;57:503-509.
16. Coulie B, Tack J, Vos R, Janssens J. Influence of the 5-HT1A agonist buspirone on rectal tone and the perception of rectal distention in man (abstr). Gastroenterology 1998;114:G3046.
17. Thumshirn M, Camilleri M, Choi MG, Zinsmeister AR. Modulation of gastric sensory and motor functions by nitrergic and alpha2-adrenergic agents in humans. Gastroenterology 1999;116:573-585.
18. Malcolm A, Camilleri M, Kost L, Burton DD, Fett SL, Zinsmeister AR. Towards identifying optimal doses for alpha-2 adrenergic modulation of colonic and rectal motor and sensory function. Aliment Pharmacol Ther 2000;14:783-793.
19. Bharucha AE, Camilleri M, Zinsmeister AR, Hanson RB. Adrenergic modulation of human colonic motor and sensory function. Am J Physiol 1997;273:G997-G1006.
20. Malcolm A, Phillips SF, Camilleri M, Hanson RB. Pharmacological modulation of rectal tone alters perception of distention in humans. Am J Gastroenterol 1997;92:2073-2079.
21. Talley NJ, Phillips SF, Melton JD, Wiltgen C, Zinsmeister AR. A patient questionnaire to identify bowel disease. Ann Intern Med 1989;111:671-674.
22. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-370.
23. Physician's desk reference (54th ed). Montvale, NJ: Medical Economics Company, 2000.
24. Mahmood I, Sahajwalla C. Clinical pharmacokinetics and pharmacodynamics of buspirone, an anxiolytic drug. Clin Pharmacokinet 1999;36:277-287.
25. Barbhaiya RH, Shukla UA, Pfeffer M, Pittman KA, Shrotriya R, Laroudie C, Gammans RE. Disposition kinetics of buspirone in patients with renal or hepatic impairment after administration of single and multiple doses. Eur J Clin Pharmacol 1994;46:41-47.
26. Porter RJ, McAllister-Williams RH, Young AH. Acute effects of venlafaxine and paroxetine on serotonergic transmission in human volunteers. Psychopharmacology 1999;146:194-198.
27. Bharucha AE, Camilleri M, Haydock S, Ferber I, Burton D, Cooper S, Tompson D, Fitzpatrick K, Higgins R, Zinsmeister AR. Effects of a serotonin 5-HT(4) receptor antagonist SB-207266 on gastrointestinal motor and sensory function in humans. Gut 2000;47:667-674.
28. Hammer HF, Phillips SF, Camilleri M, Hanson RB. Rectal tone, distensibility, and perception: reproducibility and response to different distensions. Am J Physiol 1998;274:G584-G590.
29. Ford MJ, Camilleri M, Zinsmeister AR, Hanson RB. Psychosensory modulation of colonic sensation in the human transverse and sigmoid colon. Gastroenterology 1995;109:1772-1780.
30. Viramontes BE, Malcolm A, Camilleri M, Szarka LA, McKinzie S, Burton DD, Zinsmeister AR. Effects of an alpha(2)-adrenergic agonist on gastrointestinal transit, colonic motility, and sensation in humans. Am J Physiol Gastrointest Liver Physiol 2001; 281:G1468-G1476.
31. Law NM, Bharucha AE, Undale AS, Zinsmeister AR. Cholinergic stimulation enhances colonic motor activity, transit, and sensation in humans. Am J Physiol 2001;281:G1228-G1237.
32. von der Ohe MR, Hanson RB, Camilleri M. Comparison of simultaneous recordings of human colonic contractions by manometry and a barostat. Neurogastroenterol Motil 1994;6:213-222.
33. Bassotti G, Crowell MD, Whitehead WE. Contractile activity of the human colon: lessons from 24 hour studies. Gut 1993;34:129-133.
34. Tack JF, Vos R, Broekaert D, Fischler B, Janssens J. Influence of citalopram, a selective serotonin reuptake inhibitor, on colonic tone and sensitivity in man (abstr). Gastroenterology 2000;118:A174.
35. Broekaert D, Vos R, Gevers A-M, Janssens J, Vandenberghe J, Fischler B, Tack J. A double-blind randomized placebo-controlled crossover trial of citalopram, a selective 5-hydroxytryptamine reuptake inhibitor in irritable bowel syndrome (abstr). Gastroenterology 2001;120:A641.
36. Ritchie J. Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome. Gut 1973;14:125-132.
37. Prior A, Maxton DG, Whorwell PJ. Anorectal manometry in irritable bowel syndrome: differences between diarrhoea and constipation predominant subjects. Gut 1990;31:458-462.
38. Mertz H, Naliboff B, Munakata J, Niazi N, Mayer EA. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology 1995;109:40-52.
39. Silverman DH, Munakata JA, Ennes H, Mandelkern MA, Hoh CK, Mayer EA. Regional cerebral activity in normal and pathological perception of visceral pain. Gastroenterology 1997;112:64-72.
40. Choi MG, Camilleri M, O'Brien MD, Kammer PP, Hanson RB. A pilot study of motility and tone of the left colon in patients with diarrhea due to functional disorders and dysautonomia. Am J Gastroenterol 1997;92:297-302.
41. Coulie B, Tack J, Demedts I, Vos R, Janssens J. Influence of sumatriptan on rectal tone and on the perception of rectal distention in man (abstr). Neurogastroenterol Motil 1998;10:66.